SUBSTITUTED 3-(5-MEMBERED UNSATURATED HETEROCYCLYL) -1, 3-DIHYDRO-INDOL-2-ONE DERIVATIVES AS TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF CANCER

摘要

The present invention relates to organic molecules represented by one of the general formulae I-I V capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation.